The drug & pharmaceutical industry in India meets around 70% of the country's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals and injectibles. There are about 250 large Pharmaceuticals manufacturers and suppliers and about 8000 Small Scale Pharmaceutical & Drug Units which form the core of the pharmaceutical industry in India (including 5 Central Public Sector Units). These bulk drugs and pharmaceuticals manufacturers produce the complete range of pharmaceutical formulations i.e. medicines ready for consumption by patients and about 350 bulk drugs i.e. chemicals having therapeutic value and used for production of pharmaceutical formulations. Owing to a significant increase in Pharmaceuticals exports, India's USD 3.1 billion pharmaceutical industry is growing at the rate of 14 percent per year. It is one of the largest and most advanced among the developing countries. Even the number of pharmaceuticals exporters, manufacturers and suppliers in increasing tremendously.

The production value of bulk drugs during the year 1997-98 was 2623.00 and that of pharmaceutical formulations was Rs.12068 crores. The production of pharmaceuticals in India increased by 13.68% during the year 1997-98 against the previous year. The exports of Pharmaceuticals during the year 1998-97 was Rs 49780 million. From Rs.46 crores worth of Pharmaceuticals, Drugs and Fine Chemicals exports in 1980-81, pharmaceutical exports and supplies has risen to approximately Rs. 6152 crores (Prov.1998-99), a rise of 11.91% against the last year exports. Amongst the total exports of India, the percentage share of Drugs, Pharmaceuticals and Fine Chemicals during April-October (2000-2001) was 4.1%, an increase of 7%.

Following the de-licensing of the pharmaceutical industry, industrial licensing for most of the drugs and pharmaceutical products has been done away with, manufacturers are free to produce any drug duly approved by the Drug Control Authority. Technologically strong and totally self reliant, the pharmaceutical industry in India has low costs of production, low R&D costs, innovative scientific manpower, strength of national laboratories and an increasing balance of trade.


Copyright 2008 All rights reserved.